You might have heard about the co-founder of DeepMind, Mustafa Suleyman, who was asked to take his time off from Google till the end of the year. There was no explanation why he was put on leave. However, as reported by Bloomberg last week, there were rumors linking this with some of the r
It was 1993 when young engineer Avi Yaron was asked to visit a neurologist by his father after a car accident. The first doctor confirmed he had a tumor and surgery was required right away. Realizing there could be potential complications, Yaron decided to seek a second opinion. The second neur
Depression and anxiety-related psychological disorders are costing the global economy $1 trillion annually. Between 1999 and 2013, the number of people suffering from depression and/or anxiety had increased by almost 50%, from 416 million to 615 million. Of which, as a past study found, over half of
In one of the recent AIMed Breakfast Briefings: Examining the evolving AI (artificial intelligence) landscape in Italian Healthcare (i.e., you may revisit the session here), Dr. Aurelio Secinaro, Radiologist, Bambino Gesù Children’s Hospital said we are in the intermediate space to explore the
Clinical trial is tricky. On one hand, some researchers would risk everything from the fabrication of data to publishing falsified results, to push forward their innovations. On the other hand, patients misbelieve clinical trial as their new hope. Some would share their trial results
“Is Switzerland a perfect location to begin AI?” This was a question asked at the recent AIMed Breakfast Briefing took place in Switzerland (i.e., you may revisit the session here). Speakers believe so, as explained by Dr. Christian B. Westermann, Partner & Leader of the Data & Analytic
One of the latest AIMed Breakfast Briefings: Effectively analyzing rare pediatric diseases by using the latest innovations in genomic AI technology, took place on 16 August at Innovation Institute in Newport Beach, California. Four-panel speakers including Founder and Chairman of AIMed, P
Apart from AIMed Europe 2019, which will embark in a month’s time in London, AIMed is hosting two AIMed Breakfast Briefing sessions on either end of the world, both of which taking place on the same day: Friday, 16 August 2019. Breakfast Briefing 1: Effectively analyzing rare pediatric dis
The 70-year-old public health system in the UK – the National Health Service (NHS) may not be an early adopter of artificial intelligence (AI) and related new technologies, but it is definitely an accelerator. The many roadmaps UK’s enthusiasm in the area hastened in 2017, when the Depar